78 related articles for article (PubMed ID: 17278421)
1. [Antithrombotic mechanisms of holothurian glycosaminoglycan extracted from sea cucumber].
Shen WZ; Zhou RF; Wang XF; Ding QL; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):579-83. PubMed ID: 17278421
[TBL] [Abstract][Full Text] [Related]
2. Relative quantification of glycosaminoglycan-induced upregulation of TFPI-mRNA expression in vitro.
Thyzel E; Kohli S; Siegling S; Prante C; Kleesiek K; Götting C
Thromb Res; 2007; 119(6):785-91. PubMed ID: 16919311
[TBL] [Abstract][Full Text] [Related]
3. Basic and clinical study on the antithrombotic mechanism of glycosaminoglycan extracted from sea cucumber.
Li Z; Wang H; Li J; Zhang G; Gao C
Chin Med J (Engl); 2000 Aug; 113(8):706-11. PubMed ID: 11776053
[TBL] [Abstract][Full Text] [Related]
4. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.
Hansen JB; Svensson B; Olsen R; Ezban M; Osterud B; Paulssen RH
Thromb Haemost; 2000 Jun; 83(6):937-43. PubMed ID: 10896252
[TBL] [Abstract][Full Text] [Related]
5. Effect of depolymerized holothurian glycosaminoglycan (DHG) on tissue factor pathway inhibitor: in vitro and in vivo studies.
Nagase H; Enjyoji K; Kamikubo Y; Kitazato KT; Kitazato K; Saito H; Kato H
Thromb Haemost; 1997 Aug; 78(2):864-70. PubMed ID: 9268186
[TBL] [Abstract][Full Text] [Related]
6. Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin.
Colucci M; Pentimone A; Binetti BM; Cramarossa M; Piro D; Semeraro N
Thromb Haemost; 2002 Aug; 88(2):282-7. PubMed ID: 12195701
[TBL] [Abstract][Full Text] [Related]
7. [Effects of holothuria glycosaminoglycan on the expression of tissue factor and thrombomodulin in stimulated endothelial cells].
Li Z; Wang X; Wang H; Guo W; Liu Y; Qu B; Guo X; Chu H
Zhonghua Xue Ye Xue Za Zhi; 2000 Apr; 21(4):201-4. PubMed ID: 11876983
[TBL] [Abstract][Full Text] [Related]
8. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M
Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
[TBL] [Abstract][Full Text] [Related]
9. Bemiparin and fluid flow modulate the expression, activity and release of tissue factor pathway inhibitor in human endothelial cells in vitro.
Westmuckett AD; Kakkar VV; Hamuro T; Lupu F; Lupu C
Thromb Haemost; 2001 Dec; 86(6):1547-54. PubMed ID: 11776326
[TBL] [Abstract][Full Text] [Related]
10. TAFI and pancreatic carboxypeptidase B modulate in vitro capillary tube formation by human microvascular endothelial cells.
Guimarães AH; Laurens N; Weijers EM; Koolwijk P; van Hinsbergh VW; Rijken DC
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2157-62. PubMed ID: 17673703
[TBL] [Abstract][Full Text] [Related]
11. Expression of the V264M TFPI mutant in endothelial cell cultures may involve mRNA stability.
Skretting G; Lien T; Sandset PM; Iversen N
Thromb Res; 2009 Apr; 123(6):851-5. PubMed ID: 19007969
[TBL] [Abstract][Full Text] [Related]
12. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
Brodin E; Iversen N; Hansen JB
J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
[TBL] [Abstract][Full Text] [Related]
13. Fucoidan, as heparin, induces tissue factor pathway inhibitor release from cultured human endothelial cells.
Giraux JL; Tapon-Bretaudière J; Matou S; Fischer AM
Thromb Haemost; 1998 Oct; 80(4):692-5. PubMed ID: 9798992
[TBL] [Abstract][Full Text] [Related]
14. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic effects due to pharmacological modulation of thrombin-activatable fibrinolysis inhibitor in rats.
Soni H; Sharma A; Bhatt S; Jain MR; Patel PR
Pharmacology; 2008; 82(4):304-9. PubMed ID: 18936552
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies on the topical administration of mucopolysaccharide and heparin ointments in nonhuman primates.
Hoppensteadt DA; Neville B; Schultz C; Jeske W; Raake W; Fareed J
Clin Appl Thromb Hemost; 2010 Feb; 16(1):13-20. PubMed ID: 19959490
[TBL] [Abstract][Full Text] [Related]
17. Glycosaminoglycan synthesis and shedding induced by growth factors are cell and compound specific.
Suarez ER; Nohara AS; Mataveli FD; de Matos LL; Nader HB; Pinhal MA
Growth Factors; 2007 Feb; 25(1):50-9. PubMed ID: 17454150
[TBL] [Abstract][Full Text] [Related]
18. Further insight into the heparin-releasable and glycosylphosphatidylinositol-lipid--anchored forms of tissue factor pathway inhibitor.
Ellery PE; Hardy K; Oostryck R; Adams MJ
Clin Appl Thromb Hemost; 2008 Jul; 14(3):267-78. PubMed ID: 18160611
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of inhibitory antibody derivatives towards thrombin activatable fibrinolysis inhibitor.
Develter J; Dewilde M; Gils A; Declerck PJ
Thromb Haemost; 2009 Jul; 102(1):69-75. PubMed ID: 19572070
[TBL] [Abstract][Full Text] [Related]
20. Crucial roles of GATA-2 and SP1 in adrenomedullin-affected expression of tissue factor pathway inhibitor in human umbilical vein endothelial cells exposed to lipopolysaccharide.
Liu W; Zhu ZQ; Wang W; Zu SY; Zhu GJ
Thromb Haemost; 2007 May; 97(5):839-46. PubMed ID: 17479196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
